Monte Rosa Therapeutics, Inc. short interest in 2024
In 2024, Monte Rosa Therapeutics, Inc.'s disclosed short interest ran from 3.92% of shares outstanding on 12 Jan 2024 to 14.90% on 31 Dec 2024, a change of +10.98 percentage points. The year's high was 18.17% on 15 Nov 2024 and its low 3.36% on 28 Mar 2024, averaging 6.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.57 days on 30 Apr 2024. Full history: Monte Rosa Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 3.92% (12 Jan 2024)
- End of year
- 14.90% (31 Dec 2024)
- Change
- +10.98 pp
- High
- 18.17% (15 Nov 2024)
- Low
- 3.36% (28 Mar 2024)
- Average
- 6.94%
- Highest days to cover
- 17.57 (30 Apr 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 3.92% | 8.53 | |
| 31 Jan 2024 | 3.82% | 15.56 | |
| 15 Feb 2024 | 3.95% | 14.32 | |
| 29 Feb 2024 | 3.68% | 15.16 | |
| 15 Mar 2024 | 3.64% | 14.53 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 3.36% | 9.35 | |
| 15 Apr 2024 | 3.72% | 13.95 | |
| 30 Apr 2024 | 3.82% | 17.57 | |
| 15 May 2024 | 4.61% | 15.56 | 10-Q filed, results (8-K) |
| 31 May 2024 | 3.80% | 6.38 | |
| 14 Jun 2024 | 3.95% | 8.39 | |
| 28 Jun 2024 | 5.10% | 7.94 | |
| 15 Jul 2024 | 5.71% | 11.26 | |
| 31 Jul 2024 | 5.54% | 13.96 | |
| 15 Aug 2024 | 4.55% | 15.57 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 4.99% | 11.95 | |
| 13 Sep 2024 | 5.33% | 14.10 | |
| 30 Sep 2024 | 7.13% | 8.71 | |
| 15 Oct 2024 | 8.52% | 7.08 | |
| 31 Oct 2024 | 12.77% | 1.00 | |
| 15 Nov 2024 | 18.17% | 8.67 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 18.01% | 13.02 | |
| 13 Dec 2024 | 13.69% | 3.69 | |
| 31 Dec 2024 | 14.90% | 6.89 |
See also: Monte Rosa Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.